Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07724665

Effects Of Scapulothoracic Intervention With Or Without Neural Mobilization In Patients With Cervico-Brachialgia

Cervicobrachialgia is a common musculoskeletal condition characterized by neck pain radiating into the upper limb due to neural and musculoskeletal dysfunctions. It is often associated with pain, functional disability, and increased neural mechanosensitivity, significantly affecting daily activities and quality of life. Various physiotherapy interventions have been used to manage this condition, including neural mobilization and scapulothoracic rehabilitation. However, evidence regarding the combined effectiveness of these interventions remains limited.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

30 year–50 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

About this study

The aim of the study is to determine the effects of scapulothoracic intervention with or without neural mobilization on pain, function, and neural mechanosensitivity in patients with cervicobrachialgia.

Methods: A randomized controlled trial will be conducted on 40 patients diagnosed with cervicobrachialgia. Participants will be randomly allocated into two groups, with 20 participants in each group. Group A received scapulothoracic rehabilitation combined with neural mobilization (ST+NM), while Group B received neural mobilization alone (NM). Treatment will be administered according to the study protocol over the intervention period. Outcome measures includes the Numeric Pain Rating Scale (NPRS) for pain intensity, Neck Pain Questionnaire (NPQ) for neck-related disability, PainDETECT Questionnaire (PDQ) for neuropathic pain symptoms, and Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire for upper limb function. Assessments were performed before and after the intervention. Data will be analyzed using paired sample t-tests, independent sample t-tests, Mann-Whitney U tests, and Wilcoxon Signed Rank tests with a significance level of p<0.05.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Cervicobrachial pain
  • Females and males
  • Aged 30-50 years
  • Able to communicate and follow the instructions
  • Able to perform cervical exercises according to cervicogenic pain

Exclusion criteria

  • Negative neurodynamic test
  • Neck and upper extremity surgery
  • Vertebral instability
  • Vertebral spine infection
  • Neurological disease of genetic, infection, or neuroplastic origin
  • Inflammatory or systemic disease
  • VBI symptoms
  • Rheumatoid arthritis
  • Subjects with presence of any fractures.
  • Heart/diabetic patient

Treatment and study plan

Scapulothoracic intervention with Neural Mobilization

Other

Neural Mobilization: Pain-free tension

  • Scapular Mobilization:
  • Grades III-IV joint mobs (elevation/depression/retraction)
  • 3 sets × 10 reps
  • Strengthening:
  • Serratus punches (progress to resistance bands)
  • Lower trap raises (prone Y-lifts)
  • 3 sets × 12 reps
  • Neural Mobilization:
  • ULNT1 sliding technique (6 sec hold/6 sec rest)

Neural Mobilization

Other

Neural Mobilization: Pain-free tension

  • Cervical Isometrics:
  • 4-way neck contractions (5-sec hold)
  • 3 sets × 10 reps
  • Postural Education:
  • Ergonomics training
  • Modalities:
  • TENS (80Hz, 100μs) or moist heat pack
  • Neural Mobilization:
  • ULNT1 (same as Group A)

Primary outcomes

  1. Visual Analogue Scale (VAS)

    Time frame: upto 6 weeks

    The VAS is a common, subjective measurement tool that is used to measure the level of pain severity using an 11-point range with zero (no pain) and ten (heaviest pain imaginable). Patients use a subjective scale to rate their pain verbally and the following scales apply to 1-3 mild, 4-6 moderate, and 7-10 severe pain.

  2. Northwick Park Neck Pain Questionnaire (NPQ)

    Time frame: upto 6 weeks

    The NPQ is a 9- questionnaire assessing neck pain disability with each question put on a scale of 0 to 4(code converted to percentage). It examines nocturnal sleep, activities during the day, and social goals. With cervicobrachialgia, it is used to measure functional restrictiveness such as neck/arm pain. Scores: 0-20 percent (light), 21-40 percent (moderate), >40 percent (severe).

Secondary outcomes

  1. PainDETECT questionnaire (PD-Q)

    Time frame: upto 6 weeks

    It is a 9-item instrument that has 7 scored items 0-5, and 2 items of the pain pattern characteristics of neuropathic pain in cervicobrachialgia. score 0-38: <13 (not likely neuropathic), 13-18 (indeterminate), >=19 (probable neuropathic). It assesses the quality of pain (burning, tingling etc.), radiation patterns.

  2. Disability of Arm, Shoulder and Hand (DASH)

    Time frame: upto 6 weeks

    The DASH assesses upper limb disability and is a 30 item questionnaire scaled 1-5. The total point (0-100) is counted: [(the sum of the responses/n) -1] x 25. The higher the score and the more they are disabled. The course is minimal clinically significant difference, 10 points. In case of cervicobrachialgia, it examines the impairment of arm functioning.

  3. FABF Questionnaire (FABQ)

    Time frame: upto 6 weeks

    FABQ contains 16 items consisting of two subscales namely, physical activity (4 items, 0-24) and work (7 items, 0-42). The more the score, the higher fear-avoidance. In cervicobrachialgia, scores above 14 (work) or 12 (physical activity), predict an unsatisfactory recovery.

Study contacts

Contact information is provided by the study sponsor or research team.

Sumrod Akram

CONTACT

[email protected]

03324806143

Sponsors and collaborators

Lead sponsor

Riphah International University

Other

Registry information

Official study title

Effects Of Scapulothoracic Intervention With Or Without Neural Mobilization On Pain, Function, And Neural Mechano-Sensitivity In Patients With Cervico Brachialgia

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Jul 24, 2026
Registry last updated
Jul 24, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.